StockGlow

Sprint Bioscience AB (publ) (SPRINT.ST)

Sprint Bioscience AB (publ), a pharmaceutical company, engages in the development of drug candidates to treat cancer in Sweden.

3.60-0.03%Healthcare
Compare SPRINT.ST with
StockGlow Score
74
Leaning Bullish
BearishBullish
1 year ago+564.2%

The outlook

Sprint Bioscience AB (publ) currently reads as leaning bullish based on mixed vs its moving averages, 76% of the way from its 52-week low to high, avg target +33% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendMixed vs its moving averages
52-week range76% of the way from its 52-week low to high
Price targetAvg target +33% vs current price
Market cap
$379.9M
52-wk high
4.59
52-wk low
0.51
50-day avg
3.80
200-day avg
2.41
Trailing P/E
3.8

Similar stocks

SANION.STSaniona AB (publ)$14.23+1.79%XBRANE.STXbrane Biopharma AB (publ)$10.15-1.46%CANTA.STCantargia AB (publ)$1.82+0.33%VICO.STVicore Pharma Holding AB (publ)$11.12+0.91%BINV.STBioInvent International AB (publ)$22.95-1.08%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy